Laura Spring

16PUBLICATIONS
164CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNuclear medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 27, 2025
Impact of Race/Ethnicity on Clinical and Genomic Characteristics, Trial Participation, and Genotype-Matched Therapy among Patients with Metastatic Breast Cancer.

Rupali Sood, Andrzej Niemierko, Lianne Ryan

|Jan 02, 2025
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

Rachel O Abelman, Bogang Wu, Haley Barnes

|May 06, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer.

Aditya Bardia, Sheng Sun, Nayana Thimmiah

|Nov 03, 2023
Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.

Laura M Spring, Lindsey Mortensen, Elizabeth Abraham

|Nov 02, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations.

Andreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin

|Sep 12, 2023
Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.

Martin S Taylor, Connie Wu, Peter C Fridy

Pageof 3

Frequent Collaborators

10 joint publications

Aditya Bardia

6 joint publications

Leif W Ellisen

6 joint publications

Dejan Juric

6 joint publications

Steven J Isakoff